Join
Live feed
·
INSIDERFilingvia Quantisnow
Kronos Bio Inc. logo

President & Interim CEO Knobelman Deborah closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRON (Kronos Bio Inc.) and more on Quantisnow.